NASDAQ$BLFS

BioLife Solutions Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Revenue increased significantly, driven by biopreservation media sales and acquisitions.

BioLife Solutions reported a strong third quarter with a 71% increase in total revenue compared to the prior year. The growth was fueled by increased biopreservation media sales and recent acquisitions. The company also gained 56 new customers and expanded its product offerings with the acquisition of SciSafe.

  • Total revenue increased by 71% to $11.3 million compared to Q3 2019.
  • Biopreservation media revenue increased by 22% compared to Q3 2019, accounting for 66% of total revenue.
  • 56 new customers were gained across the business.
  • SciSafe acquisition was completed, expected to contribute at least $9 million in revenue in 2021.

Headline financials

Total Revenue

$11.3M

Previous: $6.6M+70.8%
EPS (adj)

-$0.02

Previous: $0.01-300.0%
GAAP gross margin

52.0%

Previous: 64.0%-18.8%
Non-GAAP adjusted gross margin

57.0%

Previous: 69.0%-17.4%
GAAP operating loss

-$1.2M

Previous: -$772K-55.4%
Adjusted EBITDA

$1.7M

Previous: $926K+83.6%
Capital Expenditures

-$370K

Previous: -$356K-3.9%
Free Cash Flow

-$1.5M

Previous: $8.96M-116.8%
Net Income

-$1.13M

Previous: $9.32M-112.2%
Operating Income

-$1.25M

Previous: -$597K-108.7%
Gross Profit

$6.45M

Previous: $4.52M+42.8%
Cash & Equivalents

$109M

Previous: $21.2M+414.0%
Total Assets

$196M

Previous: $84.2M+132.6%
Stock-Based Comp

$1.56M

Previous: $655K+138.2%

Revenue & EPS history

BioLife · Revenue · Quarterly

$11.3M

Q3 2020+70.8%vs Q3 2019
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

BioLife · $7.68M total across 2 segments · Q3 2020

  • Cell Processing platform
    $7.4M+22.0%
  • evo and Thaw platform
    $277K

Forward guidance

Due to uncertainty regarding the impact of the COVID-19 pandemic on BioLife and its customers, on May 1, 2020 the Company withdrew its financial guidance for 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+4.3%

Avg return

30 days after

44%

22 / 50 earnings

Positive

+21.4%

Q3 2022

Best reaction

-34.5%

Q4 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.3%-2.4%+22.4%
Q4 2025+8.0%-8.1%-17.3%
Q3 2025-4.2%-4.1%-5.8%
Q2 2025+10.0%+24.4%+28.2%
Q1 2025+4.0%-1.4%+6.0%
Q4 2024+2.1%+7.6%-0.9%
Q3 2024-9.4%-21.0%+0.5%
Q2 2024+14.5%+20.3%+7.9%
Q1 2024+8.9%+25.0%+13.2%
Q4 2023+5.1%-0.5%+8.5%
Q3 2023-5.7%+3.1%+14.2%
Q2 2023-29.7%-34.9%-30.3%
Q1 2023-2.9%+3.5%+20.6%
Q4 2022+0.2%+2.7%-7.4%
Q3 2022+21.4%+14.1%-4.6%
Q2 2022+13.7%+15.7%+25.6%
Q1 2022-3.8%+1.6%+18.3%
Q4 2021-0.3%+0.9%-3.7%
Q3 2021-6.0%+5.2%-30.3%
Q2 2021-1.8%-3.9%+12.0%
Q1 2021-2.1%+4.8%+25.1%
Q4 2020+8.3%-7.8%-14.7%
Q3 2020+5.8%+0.8%+21.6%
Q2 2020+0.3%-5.4%+5.6%
Q1 2020+3.0%+10.5%+1.5%
Q4 2019-34.5%-36.7%-27.8%
Q3 2019-12.8%-8.8%-7.4%
Q2 2019-6.2%+1.1%+7.7%
Q1 2019-2.4%+4.5%+8.8%
Q4 2018+10.7%+19.4%+5.5%
Q3 2018+15.0%-8.0%-7.8%
Q2 2018-4.8%-1.0%+2.3%
Q1 2018-3.7%+7.6%+23.5%
Q4 2017-4.4%-10.2%+22.4%
Q3 2017+18.0%+21.6%+8.2%
Q2 2017+3.8%+8.2%+30.6%
Q1 2017+3.7%-1.4%+7.8%
Q4 2016-5.0%-9.5%-7.7%
Q3 2016+0.7%+2.7%+5.4%
Q2 2016-2.4%-7.7%-15.9%
Q3 2012+10.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011-14.3%
Q1 2011+0.0%
Q4 2010-11.1%
Q3 2010+0.0%
Q2 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro